4ajf: Difference between revisions
From Proteopedia
Jump to navigationJump to search
New page: '''Unreleased structure''' The entry 4ajf is ON HOLD Authors: Johansson, P., Albert, J.S., Spadola, L., Akerud, T., Back, E., Hillertz, P., Horsefeld, R., Scott, C., Spear, N., Tian, G.... |
No edit summary |
||
| (7 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
==Identification and structural characterization of PDE10 fragment inhibitors== | |||
<StructureSection load='4ajf' size='340' side='right'caption='[[4ajf]], [[Resolution|resolution]] 1.90Å' scene=''> | |||
== Structural highlights == | |||
<table><tr><td colspan='2'>[[4ajf]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4AJF OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4AJF FirstGlance]. <br> | |||
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.9Å</td></tr> | |||
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=F03:N-(4-OXO-3H-QUINAZOLIN-2-YL)ACETAMIDE'>F03</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr> | |||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4ajf FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4ajf OCA], [https://pdbe.org/4ajf PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4ajf RCSB], [https://www.ebi.ac.uk/pdbsum/4ajf PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4ajf ProSAT]</span></td></tr> | |||
</table> | |||
== Function == | |||
[https://www.uniprot.org/uniprot/PDE10_HUMAN PDE10_HUMAN] Plays a role in signal transduction by regulating the intracellular concentration of cyclic nucleotides. Can hydrolyze both cAMP and cGMP, but has higher affinity for cAMP and is more efficient with cAMP as substrate.<ref>PMID:17389385</ref> | |||
==See Also== | |||
*[[Phosphodiesterase 3D structures|Phosphodiesterase 3D structures]] | |||
== References == | |||
<references/> | |||
__TOC__ | |||
</StructureSection> | |||
[[Category: Homo sapiens]] | |||
[[Category: Large Structures]] | |||
[[Category: Aharony D]] | |||
[[Category: Akerud T]] | |||
[[Category: Albert JS]] | |||
[[Category: Back E]] | |||
[[Category: Geschwindner S]] | |||
[[Category: Hillertz P]] | |||
[[Category: Horsefeld R]] | |||
[[Category: Johansson P]] | |||
[[Category: Scott C]] | |||
[[Category: Spadola L]] | |||
[[Category: Spear N]] | |||
[[Category: Tian G]] | |||
[[Category: Tigerstrom A]] | |||
Latest revision as of 10:50, 9 May 2024
Identification and structural characterization of PDE10 fragment inhibitors
| ||||||||||||
